Related Experiment Videos
Bordetella pertussis tracheal cytotoxin
Summary
Researchers identified Tracheal Cytotoxin (TCT) from Bordetella pertussis, which selectively destroys ciliated respiratory cells. This finding explains pertussis pathology and offers a new target for therapies.
Area of Science:
- Microbiology
- Cell Biology
- Pathology
Background:
- Pertussis (whooping cough) is characterized by damage to respiratory ciliated cells.
- Virulent *Bordetella pertussis* replicates this damage in hamster tracheal cultures.
- Known toxins from *B. pertussis* do not cause this specific cytopathology.
Purpose of the Study:
- To identify and purify the component responsible for *B. pertussis*-induced ciliated cell destruction.
- To characterize the biological activity and purification of this toxin.
Main Methods:
- Purification of a glycopeptide from *B. pertussis* culture supernatant.
- Infection of hamster tracheal organ cultures with purified toxin.
- Light and electron microscopy to assess cellular damage.
- Quantitative bioassay measuring inhibition of DNA synthesis in epithelial cells.
Main Results:
- A purified glycopeptide, Tracheal Cytotoxin (TCT), selectively destroys ciliated respiratory epithelial cells.
- TCT causes dose-dependent inhibition of DNA synthesis in hamster tracheal cells.
- A new purification method using column chromatography significantly increases TCT yield.
Conclusions:
- Tracheal Cytotoxin (TCT) is the primary agent responsible for the ciliated cell pathology in pertussis.
- TCT's selective activity provides a target for understanding and potentially treating pertussis.
- Improved purification methods enable larger-scale production of active TCT for further research.